Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI

Andrea Gropman

Status: Completed

Conditions: Ornithine Transcarbamylase Deficiency

Treatments: Other: MRI scanning; Behavioral: Cognitive testing

Study type: Observational

Funder types: Other

Identifiers

NCT01569568

UCRDC 5107

Details and patient eligibility

About

The purpose of this study is to use various types of MRI and cognitive testing to evaluate changes in the brain and cognitive function that occur in subjects with ornithine transcarbamylase deficiency (OTCD) relative to healthy individuals

Full description

The overall goal of this project is to characterize metabolic, structural and cognitive changes in OTCD using 1H MRS, DTI, volumetric averaging and fMRI with cognitive testing of executive function measures to validate biomarkers for the effect of HA and its treatment on the brain.

The investigators will measure gln and mI in blood and brain (using 1H MRS) in affected participants, and mI in brain in controls, fractional anisotropy as a measure of white matter microstructural damage (by DTI) and brain activation pathways alterations with tasks probing working memory (fMRI). As a secondary outcome measure, the investigators will correlate the findings from neuroimaging with cognitive functioning. This protocol is based on the previous 5104 protocol, now includes children to evaluate the age and stage of disease on these indices in a cohort that is undergoing important developmental events against an age matched typically developing cohort.

Enrollment: 49 patients

Sex: All

Ages: 7 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Subject inclusion criteria:

1. Patients with OTCD;
2. Age range: 7-60 years
3. Able to undergo neuroimaging safely (i.e. without presence of ferromagnetic devices)
4. Subject has a documented full scale IQ > 70

Control participant inclusion criteria:

1. Healthy males and females without metabolic disease aged 7-60 years
2. Subject has a documented full scale IQ > 70

Exclusion criteria

Subject exclusion criteria:

1. Mental retardation (i.e., Full Scale IQ< 70)
2. Age range <7 or >60 years
3. Presence of ferromagnetic device(s) that preclude safe imaging
4. Pregnant female

Control exclusion criteria:

1. Subjects with a documented history of an intellectual deficit (i.e., Full Scale IQ< 70)
2. Age range <7 or >60 years
3. Presence of ferromagnetic device(s) that preclude safe imaging
4. Pregnant female

Trial design

49 participants in 2 patient groups

Subjects with OTCD

Description:

males and females ages 7-60 years with OTCD who are able to undergo MRI and cognitive testing MRI scanning 1H MRS, DTI, FMRI Cognitive testing Neuropsychological testing

Treatment:

Other: MRI scanning

Behavioral: Cognitive testing

Healthy controls

Description:

males and females ages 7-60 years who are healthy controls who are able to undergo MRI and cognitive testing MRI scanning 1H MRS, DTI, FMRI Cognitive testing Neuropsychological testing

Treatment:

Other: MRI scanning

Behavioral: Cognitive testing